AssetMemo

Therapeutic area

Psychiatry

Mood disorders, psychotic illnesses, neurodevelopmental conditions, and substance use and addiction disorders.

Core & active disease programs

Major Depressive Disorder
$127.3B+ attributable cost
67 assets · 2 indications
Schizophrenia
$36.7B+ attributable cost
$15.6B$+ drug spend
69 assets · 2 indications
Provisional & emerging programs (11)Early clinical pipeline & single-asset indications
Substance Use Disorder
4 assets· 3 indications
Bipolar Disorder
3 assets
Alzheimer's Disease Psychosis
2 assets
Attention Deficit Hyperactivity Disorder
2 assets
Social Anxiety Disorder
2 assets
Bipolar Depression
1 asset
Cocaine Intoxication
1 asset
Generalized Anxiety Disorder
1 asset
Opioid Overdose
1 asset
Parkinson's Disease Psychosis
1 asset
Post-Traumatic Stress Disorder
1 asset

All assets in Psychiatry

← all areas